Skip to main content
High RiskFDAfda-F-0723-2014OTHER

Refreshe Mixed Berry Naturally Flavored Electrolyte Water, 12 bottles per cases, 1 L per bottle, sold under Safeway brand. The UPC 0 211...

Category
Units Affected
748
Recall Date
October 24, 2013
Issuing Agency
Hazard
Other

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0723-2014.

Sweetwater Company recalls Refreshe Mixed Berry Naturally Flavored Electrolyte Water (1 L size) due to elevated amount of non-fecal total Coliforms.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0723-2014.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact The Sweetwater Co., Inc. or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0723-2014.

The Sweetwater Co., Inc.

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

The Sweetwater Co., Inc. Recall FAQ

The Sweetwater Co., Inc. is the subject of a beverages safety report: Refreshe Mixed Berry Naturally Flavored Electrolyte Water, 12 bottles per cases, 1 L per bottle, sold under Safeway brand. The UPC 0 211.... The notice was published on October 24, 2013 by the U.S. Food and Drug Administration (FDA). Approximately 748 units are potentially affected.